Science News for BCVS 2021
New Frontiers in Cardiovascular Research and Therapy
August 23–25, 2021 | A Virtual Experience
August 23–25, 2021 | A Virtual Experience
Monday's Selected Science
BCVS 2021 Program Highlights
Program Committee Chair Pilar Alcaide, MS, PhD, FAHA and Vice-Chair Sumanth Prabhu, MD, FAHA highlight some of the topics, speakers, and events they have planned for the meeting this year.
Early Career Sessions on The Next Big Thing in Cardiovascular Research
Moderators in the Early Career Sessions highlight the science presented as The Next Big Thing in Cardiovascular Research.
- Jean Chrisostome Bopassa, MS, PhD, FAHA
- Patricia Nugyen, MD
- Mo Al-khalaf, PhD
- Sarah Schumacher, PhD
More Monday Science
Comparable Impairment Of Vascular Endothelial Function By A Wide Range Of Electronic Nicotine Delivery Devices
Poonam Rao, UCSF, San Francisco, CA
An Antiplatelet Agent Sarpogrelate Suppresses Pressure Overload-induced Development Of Heart Failure In A 5-ht2aReceptor-independent Manner
Kana Shimizu, Univ of Shizuoka, Shizuoka, Japan
Tuesday's Selected Science
COVID-19 and Myocardial Injury
Moderators Milka Koupenova, PhD and Eduardo Marbán, MD, PhD discuss the science presented in the Concurrent Session "COVID-19 and Myocardial Injury: Short- and Long-Term Cardiovascular Effects.”
Inflammation and HFpEF
Julie B. Bossuyt, DVM and Kory J. Lavine, MD, PhD recap the science from the poster session they moderated on "Inflammation and HFpEF."
Wednesday's Selected Science
Outstanding Early Career Investigator Award Winner
Glynnis Gary, MD interviews the winner of this year’s Outstanding Early Career Investigator Award, Christopher Toepfer, PhD about his work on differentiating the disease pathomechanisms of different types of hypertrophic cardiomyopathy.
Interview with BCVS 2021 Keynote Lecturer Douglas L. Mann, MD
Program Committee Chair Pilar Alcaide, MS, PhD, FAHA interviews Douglas L. Mann, MD about his Keynote Lecture, “The Role of Innate Inflammation in Cardiac Injury and Repair.”